GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Adastra Holdings Ltd (XCNQ:XTRX) » Definitions » Valuation Rank

Adastra Holdings (XCNQ:XTRX) Valuation Rank


View and export this data going back to 2020. Start your Free Trial

What is Adastra Holdings Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Adastra Holdings Valuation Rank Related Terms

Thank you for viewing the detailed overview of Adastra Holdings's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Adastra Holdings (XCNQ:XTRX) Business Description

Traded in Other Exchanges
Address
275th Street, Suite 5451, Langley, BC, CAN, V4W 3X8
Adastra Holdings Ltd is an extraction and processing solutions company. It aims to develop and deploy large-scale cannabis and hemp extraction technologies and provide turnkey processing solutions to help licensed standard and micro-cultivators maximize the value of every harvest. The company has two operating segments comprised of manufacturing and non-manufacturing operations. The manufacturing operations include the manufacturing, sale, and distribution of cannabis-related products, and the non-manufacturing operations include PerceiveMD.
Executives
Lachlan Clyde Mcleod Senior Officer